title: Abnormal relaxin secretion during pregnancy in women with type 1 diabetes.
abstract: To test the hypothesis that relaxin may play a role in the fetal abnormalities associated with pregnancy in type 1 diabetic women, we previously compared gestational relaxin concentrations in diabetic and clinically normal women using a porcine relaxin radioimmunoassay (RIA): Serum immunoactive relaxin was significantly (P < 0.001) elevated in the diabetic women. To confirm and extend this work in a larger group of subjects, we have now used an enzyme-linked immunosorbent assay (ELISA) specific for human H2 relaxin (the normal human gene product) to determine immunoactive serum relaxin concentrations in serial samples from 61 Type 1 diabetic and 21 normal pregnant women. Samples from 22 of the diabetic and nine of the normal women were also directly compared in the porcine relaxin RIA. ELISA-determined serum relaxin was higher (P < 0.001) at 24 and 36 weeks of pregnancy in type 1 diabetic women than in controls, confirming previous findings. However, the geometric mean increase in immunoactive relaxin concentration in identical samples from pregnant diabetic women over that of controls was significantly greater with the RIA than with the ELISA (271% vs 44%; P < 0.001). To investigate this discrepancy, the specificity and epitope selectivity of the RIA and the ELISA were compared using several synthetic polypeptides, including human relaxins H1 and H2, and relaxin and insulin derivatives. Both assays showed great specificity, but the porcine RIA selectively identified the epitopes of the receptor-binding domain of the relaxin B chain and cross-reacted strongly with H1 and H2 relaxins. In contrast, only the H2 peptide was detected by the ELISA antiserum. Therefore, the marked discrepancy between the RIA and the ELISA could be due to the presence in the diabetic samples of another relaxin-like molecule in addition to the normal H2 relaxin. The biological consequences of elevated serum relaxin in diabetic pregnancy remain to be elucidated.
authors.affiliation: Department of Obstetrics and Cleft Palate Research Unit, Royal Victoria Infirmary, Newcastle, Tyne and Wear, NE1 4LP, United Kingdom.
authors.forename: Paul G
authors.initials: PG
authors.lastname: Whittaker
authors.forename: J R G
authors.initials: JR
authors.lastname: Edwards
authors.forename: Carla
authors.initials: C
authors.lastname: Randolph
authors.forename: Erika E
authors.initials: EE
authors.lastname: Büllesbach
authors.forename: Christian
authors.initials: C
authors.lastname: Schwabe
authors.forename: Bernard G
authors.initials: BG
authors.lastname: Steinetz
mesh_terms: D000818:Animals; D003429:Cross Reactions; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007328:Insulin / Q000737:chemistry / Q000276:immunology; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D011863:Radioimmunoassay; D012065:Relaxin / Q000097:blood / Q000276:immunology / Q000378:metabolism*; D013552:Swine
chemical_list: D007328:Insulin; D012065:Relaxin